Photodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular density

Lasers in Surgery and Medicine

Volumn 44, Issue 4, 2012, Pages 318-324

  Wang, Yabo ^a   Gonzalez, Michel ^a   Cheng, Cai ^a   Haouala, Amina ^a   Krueger, Thorsten ^a   Peters, Solange ^a   Decosterd, Laurent Arthur ^a   Van Den Bergh, Hubert ^b   Perentes, Jean Y ^a   Ris, Hans Beat ^a   Letovanec, Igor ^a   Debefve, Elodie ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

Author keywords

adenocarcinoma; chemotherapy; lung; mesothelioma; photodynamic therapy; sarcoma

Indexed keywords

DOXORUBICIN; LIPORUBICIN; UNCLASSIFIED DRUG; VERTEPORFIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FISCHER 344 RAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG SARCOMA; LUNG TUMOR; MALE; MESOTHELIOMA; MORPHOMETRICS; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; TUMOR VASCULARIZATION; VASCULAR TUMOR;

ADENOCARCINOMA; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; LIPOSOMES; LUNG NEOPLASMS; MALE; MESOTHELIOMA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RATS; RATS, INBRED F344; SARCOMA; TREATMENT OUTCOME;

EID: 84859766320     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22013     Document Type: Article

References (34)

1. Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ,. Photodynamic therapy in oncology. Exp Opin Pharmacother 2001; 2: 917-927.
2. Henderson BW, Gollnick SO,. Mechanistic principles of photodynamic therapy. In:, Vo-Dinh T, editor. Biomedical photonics handbook. Boca Raton, Florida: CRC Press; 2003. pp 36-1-36-27.
3. Ris HB, Altermatt HJ, Inderbitzi R, Hess R, Nachbur B, Stewart JC, Wang Q, Lim CK, Bonnett R, Berenbaum MC, Althaus U,. Photodynamic therapy with chlorines for diffuse malignant mesothelioma: Initial clinical results. Br J Cancer 1991; 64: 1116-1120.
4. Ris HB, Altermatt HJ, Nachbur B, Stewart CM, Wang Q, Lim CK, Bonnett R, Althaus U,. Intraoperative photodynamic therapy with m-tetra- hydroxyphenylchlorin for chest malignancies. Lasers Surg Med 1996; 18: 39-45.
5. Baas P, Murrer L, Zoetmulder FA, Stewart FA, Ris HB, van Zandwijk N, Peterse JL, Rutgers EJ,. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer 1997; 76: 819-826.
6. Pass HI, Temeck BK, Kranda K, Feuerstein I, Steinberg SM,. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 1997; 4: 628-633.
7. Moskal TL, Dougherty TJ, Urschel JD, Antkowiak JG, Regal AM, Driscoll DL, Takita H,. Operation and photodynamic therapy for pleural mesothelioma: 6-Year follow-up. Ann Thorac Surg 1998; 66: 1128-1133.
8. Friedberg JS, Mick R, Stevenson JP, Zhu T, Busch TM, Shin D, Smith D, Culligan M, Dimofte A, Glatstein E, Hahn SM,. Phase II trial of pleural photodynamic therapy and surgery for patients with non small cell lung cancer with pleural spread. J Clin Oncol 2004; 22: 2192-2201.
9. Friedberg JS, Mick R, Culligan M, Stevenson J, Fernandes A, Smith D, Glatstein E, Hahn SM, Cengel K,. Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma. Ann Thorac Surg 2011; 91: 1738-1746.
10. Fingar VH,. Vascular effects of photodynamic therapy. J Clin Laser Med Surg 1996; 14: 323-328.
11. Debefve E, Pegaz B, van den Bergh H, Wagnières G, Lange N, Ballini JP,. Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model. Angiogenesis 2008; 11: 235-243.
12. Snyder JW, Greco WR, Bellnier DA, Vaughan L, Henderson BW,. Photodynamic therapy: A means to enhanced drug delivery to tumors. Cancer Res 2003; 63: 8126-8131.
13. Cheng C, Debefve E, Haouala A, Andrejevic-Blant S, Krueger T, Ballini JP, Peters S, Decosterd L, van den Bergh H, Wagnieres G, Perentes JY, Ris HB,. Photodynamic therapy selectively enhances liposomal doxorubicin uptake in sarcoma tumors grown on rodent lungs. Lasers Surg Med 2010; 42: 391-399.
14. Keller AM, Mennel RG, Georgoulias VA, Nabholtz JM, Erazo A, Lluch A, Vogel CL, Kaufmann M, von Minckwitz G, Henderson IC, Mellars L, Alland L, Tendler C,. Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer. J Clin Oncol 2004; 22: 3893-3901.
15. O'Shaughnessy JA,. Pegylated liposomal doxorubicin in the treatment of breast cancer. Clin Breast Cancer 2003; 4: 318-328.
16. Gordon AN, Fleagle JT, Guthrie D, Parkin DE, Gore ME, Lacave AJ,. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. J Clin Oncol 2001; 19: 3312-3322.
17. Numico G, Castiglione F, Granetto C, Garrone O, Mariani G, Costanzo GD, Ciura PL, Gasco M, Ostellino O, Porcile G, Merlano M,. Single-agent pegylated liposomal doxorubicin (Caelix) in chemotherapy pretreated non-small cell lung cancer patients: A pilot trial. Lung Cancer 2002; 35: 59-64.
18. Lees AW, Hoy W,. Management of pleural effusions in breast cancer. Chest 1979; 75: 51-53.
19. Poe RH, Qazi R, Israel RH, Wicks CM, Rubins JM,. Survival of patients with pleural involvement by breast carcinoma. Am J Clin Oncol 1983; 6: 523-527.
20. Pan Y, Krueger T, Tran N, Yan H, Ris HB, McKee TA,. Evaluation of tumour vascularisation in two rat sarcoma models for studying isolated lung perfusion. Injection route determines the origin of tumour vessels. Eur Surg Res 2005; 37: 92-99.
21. Kucharczuk JC, Elshami AA, Zhang HB, Smythe WR, Hwang HC, Tomlinson JS, Amin KM, Litzky LA, Albelda SM, Kaiser LR,. Pleural-based mesothelioma in immune competent rats: A model to study adenoviral gene transfer. Ann Thorac Surg 1995; 60: 593-597.
22. Xing RH, Mazar A, Henkin J, Rabbani SA,. Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428. Cancer Res 1997; 57: 3585-3593.
23. Krueger T, Pan Y, Tran N, Altermatt HJ, Opitz I, Ris HB,. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats. Lasers Surg Med 2005; 37: 271-277.
24. Yan H, Cheng C, Haouala A, Krueger T, Ballini JP, Peters S, Decosterd LA, Letovanec I, Ris HB,. Distribution of free and liposomal doxorubicin after isolated lung perfusion in a sarcoma mode. Ann Thorac Surg 2008; 85: 1225-1232.
25. Goddard JC, Sutton CD, Furness PN, Kockelbergh RC, O'Byrne KJ,. A computer image analysis system for microvessel density measurement in solid tumours. Angiogenesis 2002; 5: 15-20.
26. Sharma S, Sharma MC, Sarkar C,. Morphology of angiogenesis in human cancer: A conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005; 46: 481-489.
27. Jain RK,. The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors. Microcirculation 1997; 4: 1-23.
28. Jain RK,. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 2005; 307: 58-62.
29. Bessler NM,. Verteporfin therapy in age-related macular degeneration (VAM): An open-label multicenter photodynamic therapy study of 4,435 patients. Retina 2004; 24: 512-520.
30. Opitz I, Krueger T, Pan Y, Altermatt HJ, Wagnieres G, Ris HB,. Preclinical comparison of mTHPC and verteporfin for intracavitary photodynamic therapy of malignant pleural mesothelioma. Eur Surg Res 2006; 38: 333-339.
31. Gabizon AA,. Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 1992; 52: 891-896.
32. Ris HB, Li Q, Krueger T, Lim CK, Reynolds B, Althaus U, Altermatt HJ,. Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: Correlation with sensitizer uptake, tumor doubling time and tumor histology. Int J Cancer 1998; 76: 872-874.
33. Debefve E, Cheng C, Schaefer SC, Yan H, Ballini JP, van den Bergh H, Lehr HA, Ruffieux C, Ris HB, Krueger T,. Photodynamic therapy induces selective extravasation of macromolecules: Insights using intravital microscopy. J Photochem Photobiol B 2010; 98: 69-76.
34. Debefve E, Mithieux F, Perentes JY, Wang Y, Cheng C, Schaefer SC, Ruffieux C, Ballini J-P, Gonzalez M, van den Bergh H, Ris H-B, Lehr H-A, Krueger T,. Leukocyte-endothelial cell interaction is necessary for photodynamic therapy induced vascular permeabilization. Lasers Surg Med 2011; 43: 696-704.